ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,826Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 6969

$2.76M Total Retail Price of All Prescriptions

Rank: 12 out of 6969

625 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 625 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 26,584 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$99 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ATELVIA 953 936 1 111
LIDODERM 796 778 2 75
AMLODIPINE BESYLATE 764 741 3 4
EFFIENT 668 646 10 4 272
BENICAR 650 599 10 5 107
CRESTOR 638 633 6 39
CLOPIDOGREL 562 550 7 48
CELEBREX 536 509 8 67
ATORVASTATIN CALCIUM 536 516 8 11
ATENOLOL 520 505 10 9
PATADAY 487 454 11 213
DIOVAN 466 466 12 26
COREG CR 451 426 10 13 252
TAMSULOSIN HCL 418 418 14 23
AMOXICILLIN 415 381 15 99
EVISTA 415 404 15 118
PLAVIX 398 392 17 68
LEVOTHYROXINE SODIUM 388 359 18 5
ALENDRONATE SODIUM 383 374 19 14
DIOVAN HCT 376 376 20 57
SIMVASTATIN 365 344 21 1
METFORMIN HCL 334 319 22 7
SINGULAIR 330 302 23 84
TRIAMCINOLONE ACETONIDE 324 310 24 55
ZOLPIDEM TARTRATE 315 297 25 16
NEXIUM 283 266 26 52
CARVEDILOL 280 280 27 25
OMEPRAZOLE 279 257 28 6
FLUOCINONIDE 277 263 29 134
DONEPEZIL HCL 272 272 30 32
FLECTOR 272 272 10 30 264
CIPROFLOXACIN HCL 263 243 32 64
BENICAR HCT 252 245 33 176
ACTONEL 251 244 34 115
TEKTURNA 242 242 10 35 295
MELOXICAM 236 232 36 36
HYDROCHLOROTHIAZIDE 233 226 37 8
ONGLYZA 216 185 38 164
SPIRIVA 214 188 39 66
BYSTOLIC 213 204 40 155
AVODART 209 197 41 108
NAPHAZOLINE HCL 203 195 42 245
MONTELUKAST SODIUM 202 183 43 151
DEXILANT 202 192 43 110
LOVAZA 199 188 45 77
ACTOS 189 178 46 61
LOSARTAN POTASSIUM 187 179 47 12
LYRICA 186 174 48 137
ACTOPLUS MET 182 168 49 266
PREDNISONE 174 162 50 70
AZITHROMYCIN 173 166 51 42
ACIPHEX 171 164 52 181
CREON 166 164 53 147
VOLTAREN 165 164 54 105
LANSOPRAZOLE 154 154 55 171
ALLOPURINOL 154 154 55 35
HYDROXYZINE HCL 152 139 R 57 159
ISOSORBIDE MONONITRATE ER 151 151 58 81
LOVASTATIN 151 136 58 15
LIPITOR 151 146 58 89
FAMOTIDINE 141 124 61 37
EXFORGE 139 139 62 190
JANUVIA 132 132 63 41
AZOR 131 131 64 233
PROLIA 130 129 65 386
MECLIZINE HCL 126 125 66 100
METHIMAZOLE 125 119 67 345
NASONEX 125 113 67 144
GLIPIZIDE 123 111 69 21
CEPHALEXIN 122 117 70 96
LOSARTAN-HYDROCHLOROTHIAZIDE 121 121 71 53
METOPROLOL TARTRATE 114 110 72 13
BENAZEPRIL HCL 107 92 73 18
JALYN 106 106 74 339
GLYBURIDE 104 104 R 75 54
BETAMETHASONE DIPROPIONATE 102 98 76 250
GLYBURIDE-METFORMIN HCL 101 89 R 77 92
AMITIZA 94 94 78 254
MEGESTROL ACETATE 92 90 R 79 129
NAMENDA 91 91 80 51
CLONIDINE HCL 90 90 81 59
PANTOPRAZOLE SODIUM 89 89 82 31
PIOGLITAZONE-METFORMIN 89 79 R 10 82 453
EPINASTINE HCL 89 89 82 425
PROAIR HFA 88 82 85 33
ENABLEX 88 88 85 299
PIOGLITAZONE HCL 86 83 R 87 174
VESICARE 85 73 88 163
TRILIPIX 82 70 89 175
CEFTRIAXONE 81 80 90 343
PROCTOZONE-HC 81 77 90 293
FINASTERIDE 81 81 90 80
FLUTICASONE PROPIONATE 81 68 90 24
ROPINIROLE HCL 78 78 94 162
CYMBALTA 78 66 94 72
GEMFIBROZIL 75 63 96 85
NIFEDIPINE ER 75 75 96 95
DIPHENOXYLATE-ATROPINE 72 69 98 214
ACETAMINOPHEN-CODEINE 69 62 S3 99 73
VIREAD 68 65 100 288
ULORIC 67 67 101 243
PROPRANOLOL HCL 67 67 101 153
GABAPENTIN 67 59 101 17
IBUPROFEN 67 64 101 29
LIDOCAINE HCL 67 67 101 456
CLOTRIMAZOLE-BETAMETHASONE 66 65 106 182
ISOSORBIDE DINITRATE 65 65 107 231
GLIMEPIRIDE 64 64 108 44
BENAZEPRIL-HYDROCHLOROTHIAZIDE 63 53 109 132
DILTIAZEM 24HR CD 62 52 110 191
ADVAIR DISKUS 55 55 111 45
NATEGLINIDE 55 34 111 228
TEKTURNA HCT 54 54 113 481
NAPROXEN 54 50 113 62
SYMBICORT 53 53 115 149
CHLORHEXIDINE GLUCONATE 53 53 115 384
THEOPHYLLINE ANHYDROUS 53 53 115 287
METOCLOPRAMIDE HCL 51 51 118 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 22, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.